Artiva Biotherapeutics (ARTV) vs Surrozen (SRZN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Artiva Biotherapeutics is the larger company by market cap ($342.2 million vs $295.5 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ARTV | SRZN |
|---|---|---|
| Share price | $7.00 | $25.15 |
| Market cap | $342.23M | $295.54M |
| 1-day change | -3.71% | -4.65% |
| YTD return | +63.17% | — |
| 1-year return | +141.38% | — |
| EPS (TTM) | $-3.23 | $-39.08 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.53 | $37.83 |
| 52-week low | $2.71 | $11.39 |
| Distance from 52-week high | -51.82% | -33.53% |
| Average volume | 404.69K | 471.01K |
| Shares outstanding | 48.89M | 11.75M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ARTV vs SRZN FAQ
Which is bigger, Artiva Biotherapeutics or Surrozen?
Artiva Biotherapeutics (ARTV) is larger, with a market capitalization of $342.23M compared with $295.54M for Surrozen (SRZN).
Are Artiva Biotherapeutics and Surrozen in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.